Wells Fargo’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $342K | Sell |
23,369
-39,254
| -63% | -$626K | ﹤0.01% | 4358 |
|
|
2025
Q4 | $482K | Buy |
62,623
+26,228
| +72% | +$207K | ﹤0.01% | 4526 |
|
|
2025
Q3 | $268K | Buy |
36,395
+9,325
| +34% | +$47.7K | ﹤0.01% | 4755 |
|
|
2025
Q2 | $108K | Buy |
27,070
+25,070
| +1,254% | +$91.2K | ﹤0.01% | 5140 |
|
|
2025
Q1 | $6.36K | Buy |
2,000
+1,831
| +1,083% | +$8.62K | ﹤0.01% | 5981 |
|
|
2024
Q4 | $904 | Buy |
+169
| New | +$1.26K | ﹤0.01% | 6267 |
|
|
2024
Q2 | – | Sell |
-265
| Closed | -$472 | – | 7014 |
|
|
2024
Q1 | $472 | Buy |
265
+5
| +2% | +$10 | ﹤0.01% | 6291 |
|
|
2023
Q4 | $458 | Buy |
260
+13
| +5% | +$19 | ﹤0.01% | 6404 |
|
|
2023
Q3 | $361 | Sell |
247
-1
| -0.4% | -$2 | ﹤0.01% | 6434 |
|
|
2023
Q2 | $568 | Buy |
248
+10
| +4% | +$21 | ﹤0.01% | 6457 |
|
|
2023
Q1 | $217 | Buy |
238
+3
| +1% | +$2 | ﹤0.01% | 6754 |
|
|
2022
Q4 | $200 | Buy |
235
+6
| +3% | +$5 | ﹤0.01% | 6623 |
|
|
2022
Q3 | $0 | Buy |
229
+11
| +5% | +$10 | ﹤0.01% | 6755 |
|
|
2022
Q2 | $0 | Buy |
+218
| New | +$267 | ﹤0.01% | 6899 |
|
|
2021
Q4 | – | Sell |
-182
| Closed | -$1K | – | 7294 |
|
|
2021
Q3 | $1K | Buy |
182
+17
| +10% | +$50 | ﹤0.01% | 6678 |
|
|
2021
Q2 | $0 | Buy |
165
+1
| +0.6% | +$3 | ﹤0.01% | 6962 |
|
|
2021
Q1 | $1K | Buy |
164
+60
| +58% | +$217 | ﹤0.01% | 6698 |
|
|
2020
Q4 | $0 | Buy |
104
+6
| +6% | +$24 | ﹤0.01% | 6534 |
|
|
2020
Q3 | $0 | Buy |
98
+19
| +24% | +$76 | ﹤0.01% | 6388 |
|
|
2020
Q2 | $0 | Hold |
79
| – | – | ﹤0.01% | 6346 |
|
|
2020
Q1 | $0 | Buy |
+79
| New | +$321 | ﹤0.01% | 6274 |
|
|
2019
Q3 | – | Sell |
-676
| Closed | -$3K | – | 6416 |
|
|
2019
Q2 | $3K | Sell |
676
-24,339
| -97% | -$95.4K | ﹤0.01% | 6108 |
|
|
2019
Q1 | $101K | Sell |
25,015
-16
| -0.1% | -$68 | ﹤0.01% | 5120 |
|
|
2018
Q4 | $92K | Buy |
25,031
+21,049
| +529% | +$144K | ﹤0.01% | 5323 |
|
|
2018
Q3 | $34K | Buy |
3,982
+430
| +12% | +$4.3K | ﹤0.01% | 5713 |
|
|
2018
Q2 | $39K | Buy |
3,552
+370
| +12% | +$4.13K | ﹤0.01% | 5658 |
|
|
2018
Q1 | $37K | Buy |
3,182
+19
| +0.6% | +$180 | ﹤0.01% | 5651 |
|
|
2017
Q4 | $33K | Sell |
3,163
-3,777
| -54% | -$48.4K | ﹤0.01% | 5665 |
|
|
2017
Q3 | $111K | Buy |
6,940
+3,534
| +104% | +$48.9K | ﹤0.01% | 5190 |
|
|
2017
Q2 | $41K | Buy |
3,406
+6
| +0.2% | +$64 | ﹤0.01% | 5444 |
|
|
2017
Q1 | $71K | Buy |
3,400
+2,500
| +278% | +$39.2K | ﹤0.01% | 5330 |
|
|
2016
Q4 | $13K | Sell |
900
-500
| -36% | -$7.6K | ﹤0.01% | 5731 |
|
|
2016
Q3 | $23K | Buy |
1,400
+700
| +100% | +$10.1K | ﹤0.01% | 5565 |
|
|
2016
Q2 | $10K | Buy |
+700
| New | +$9.46K | ﹤0.01% | 5662 |
|
Other funds holding CRVS
O
ASP
VCM
VC
DTC
